|
RADIATION THERAPY: WHEN, HOW FOR WHOM
Chair: R. Orecchia
Rapporteur: G. Gatti |
| 8.15 |
Innovations in Intraoperative Electron beams
radiotherapy
R. Orecchia |
| 8.30 |
Candidates for Intraoperative Photons radiotherapy
J.S. Vaidya |
| 8.45 |
Brachytherapy: the new parameters
C. Polgar |
| 9.00 |
IART: a perspective new development
G. Paganelli |
| 9.15 |
Discussion |
|
ENDOCRINE ADJUVANT THERAPIES: ONGOING
RESEARCH. DO WE HAVE NEW STANDARDS?
Chair: E. Bajetta
Rapporteur: E. Munzone |
| 9.30 |
Aromatase inhibitors for whom, when and how long?
E. Winer |
| 9.45 |
How to treat young women with operated breast cancer?
N. Davidson |
| 10.00 |
Economical implications
B. Hillner |
| 10.15 |
Discussion |
| 10.30 |
Coffee Break |
| 11.00 |
SPOTLIGHT
HER2/NEU: TAILORING TARGETED TREATMENTS
A. Goldhirsch |
| 11.20 |
The Milan Breast Cancer
Observatory:
Innovation and care in the next 12 months
Participants:
F. Cardoso - A. Coates - N. Davidson -
V. Galimberti
A. Goldhirsch -
K. Sandelin - D. Slamon - E. Winer
Chair: A. Costa |
| 12.20 |
Lunch |
| 13.30 |
SPOTLIGHT:
Innovations in bone management for women
with breast cancer
R. E. Coleman |
|
PREOPERATIVE SYSTEMIC THERAPIES: TAILORED APPROACH
Chair: A. Coates
Rapporteur: R. Torrisi |
| 13.50 |
Criteria for selecting preoperative systemic therapies
for women with operable breast cancer
L. Gianni |
| 14.05 |
Tailored preoperative systemic
therapies: what and for how long?
M. Colleoni |
| 14.20 |
Discussion |
|
ADJUVANT TREATMENT FOR SPECIAL POPULATIONS
Chair: F. Boccardo
Rapporteur: F. Peccatori |
| 14.35 |
Women with autoimmune disease
S. Bernatsky |
| 14.50 |
Women with cognitive disorders
A. Coates |
| 15.05 |
Breast cancer in lymphoma survivors
S. Cinieri |
| 15.20 |
Discussion |
| 15.35 |
Coffee Break |
|
APPROACHING COMPLICATIONS OF METASTATIC BREAST CANCER AND PARANEOPLASTIC
SYNDROMES. WHAT’S NEW?
Chair: N. Davidson
Rapporteur: G. Sanna |
| 16.05 |
Surgery in bone metastases:
something new?
A.P. Daolio |
| 16.20 |
CNS metastatic involvement
E. Winer |
| 16.35 |
Paraneoplastic syndromes
G. Curigliano |
| 16.50 |
Discussion |
|
Symposium |
|
THE OLDER WOMAN WITH BREAST CANCER
Chair: A. Surbone
Rapporteur: S. Dellapasqua |
| 17.05 |
Clinical challenges in treating elderly breast cancer
patients: myth or reality?
N. Davidson |
| 17.20 |
Overview of ongoing trials in elderly breast cancer
patients: US and European perspectives
M. Extermann |
| 17.35 |
Discussion and Closing remarks |
HOME PAGE
Wed, 21 june 2006